| For: | Qiu Y, Tang Q, Liu XQ, Xue YL, Zeng Y, Hu P. Hepatitis B core-related antigen as a promising serological marker for monitoring hepatitis B virus cure. World J Hepatol 2025; 17(1): 98658 [PMID: 39871916 DOI: 10.4254/wjh.v17.i1.98658] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v17/i1/98658.htm |
| Number | Citing Articles |
| 1 |
Nastaran Arab, Morteza Hosseini. Electrochemical Insights into Bioinorganic Systems. 2026; doi: 10.1039/9781837678945-00235
|
| 2 |
Yuki Nakaya, Takema Hasegawa, Yuji Hoshi, Daichi Onomura, Tomoko Yamagata, Hiroaki Okamoto, Kazumoto Murata, Megumi Kato. Development of a hypersensitive digital ELISA system for hepatitis B core antigen. Analytical and Bioanalytical Chemistry 2026; 418(7) doi: 10.1007/s00216-026-06338-z
|
| 3 |
Kanyakorn Singsung, Athaya Vorasittha, Pisit Tangkijvanich, Yasuhito Tanaka, Natthaya Chuaypen, Pongserath Sirichindakul. Host Factors DDB2 and DNA Polymerase Delta Are Linked to cccDNA Persistence in Hepatitis B Virus and Occult Hepatitis B Virus‐Related Hepatocellular Carcinoma. Journal of Viral Hepatitis 2026; 33(6) doi: 10.1111/jvh.70182
|
| 4 |
Masanori Fukushima, Satoshi Miuma, Yasuhiko Nakao, Ryu Sasaki, Masafumi Haraguchi, Hisamitsu Miyaaki. Greater Reductions in Hepatitis B Core-Related Antigen Associated with Switching from Entecavir to Tenofovir Alafenamide Compared with Continued Entecavir Therapy: A Retrospective Observational Study. Journal of Clinical Medicine 2026; 15(11) doi: 10.3390/jcm15114021
|
| 5 |
Junjie Liu, Tong Yuan, Lin Xue, Huifang Liang. Pathogenesis, prevention, and therapeutic advances in hepatitis B, C, and D. Virology Journal 2025; 22(1) doi: 10.1186/s12985-025-02907-3
|
| 6 |
Shulin Xia, Xiaomin He, Jianhe Gan, Jiachen Ding. Impact of PC/BCP Mutations on Seroconversion and Relapse in HBeAg-Positive Chronic Hepatitis B Patients Treated with Nucleoside Analogues. Infection and Drug Resistance 2025; doi: 10.2147/IDR.S536426
|